Produktinformation
- (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate salicylate
- Benzoic acid
- 2-hydroxy-
- compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI)
- Benzoic acid
- 2-hydroxy-
- compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
- Physostigmine salicylate (6CI)
- Physostigmine
- monosalicylate (8CI)
- Mehr Synonyme anzeigen
- Pyrrolo[2,3-b]indol-5-ol
- 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-
- methylcarbamate (ester)
- (3aS,8aR)-
- mono(2-hydroxybenzoate) (salt) (9CI)
- Pyrrolo[2,3-b]indol-5-ol
- 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-
- methylcarbamate (ester)
- (3aS-cis)-
- mono(2-hydroxybenzoate) (salt)
- Salicylic acid
- compd. with physostigmine (1:1) (8CI)
- Eserine salicylate
- Isopto Eserine
- (3aS,8aR)-1,3a,8-trimethyl-5-[(methylcarbamoyl)oxy]-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indolediium 2-oxidobenzoate
- 2-hydroxybenzoic acid - (3aS)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
- Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl N-methylcarbamate (1:1)
- Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
- Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
- Eserine salicylate salt
- Physostigmine salicylate
- Physostigmine, monosalicylate
- Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, mono(2-hydroxybenzoate) (salt)
- Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt)
- Salicylic acid, compd. with physostigmine (1:1)
Applications Physostigmine Salicylate is a cholinesterase inhibitor with the potential to improve cognitive ability in individuals with alzheimers. In addition, as a parasympathomimetic, it is used to treat glaucoma, dry mouth, and delayed gastric emptying.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Thal, L. et al.: Neurol., 47, 1389 (1996); Hedner, E. et al.: Eur. J. Oral Sci., 109, 374 (2001);
Chemische Eigenschaften
Technische Anfrage zu: TR-P398510 Physostigmine Salicylate
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.